| Health / Medical Topics |
PEG-rhMGDF
A form of megakaryocyte growth and development factor (MGDF) that is made in the laboratory. MGDF comes from the protein thrombopoietin, which is normally made in the body to help make platelets. PEG-rhMGDF is being studied as a way to increase the number of platelets in patients receiving chemotherapy. Also called PEG-MGDF and polyethylene glycosylated recombinant human megakaryocyte growth and development factor. (NCI Dictionary)
YOU MAY ALSO LIKE
A long-acting formulation of recombinant interferon alpha subtype 2b (IFN-a2b) protein, in which IFN-a2b is coupled, via proline, to polyethylene glycol (PEG),…
A form of megakaryocyte growth and development factor (MGDF) that is made in the laboratory. MGDF comes from the protein thrombopoietin, which…
A proprietary 44-nucleotide L-stereoisomer RNA oligonucleotide conjugated to a 40 kDa polyethylene glycol (PEG) that targets hepcidin with potential anti-anemic activity. Upon…
A drug used to treat hepatitis C infections. PEG-Intron is a brand name for peginterferon alfa-2b. It is a type of…
A complex of polyethylene glycol conjugated with human recombinant cytokine interleukin-2 (IL-2) with antineoplastic activity. PEG-interleukin-2 induces natural killer (NK) cell activity…
A pegylated form of glutaminase-asparaginase developed to decrease immunogenicity.
